- Home
- CLPS vs TENX Comparison
CLPS vs TENX Comparison
Compare CLPS & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- TENX
- Stock Information
- Founded
- CLPS 2005
- TENX 1967
- Country
- CLPS Hong Kong
- TENX United States
- Employees
- CLPS N/A
- TENX N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- TENX Health Care
- Exchange
- CLPS Nasdaq
- TENX Nasdaq
- Market Cap
- CLPS 26.8M
- TENX 27.3M
- IPO Year
- CLPS 2018
- TENX N/A
- Fundamental
- Price
- CLPS $0.88
- TENX $6.96
- Analyst Decision
- CLPS
- TENX Strong Buy
- Analyst Count
- CLPS 0
- TENX 2
- Target Price
- CLPS N/A
- TENX $17.00
- AVG Volume (30 Days)
- CLPS 313.2K
- TENX 72.3K
- Earning Date
- CLPS 10-17-2025
- TENX 11-14-2025
- Dividend Yield
- CLPS 14.77%
- TENX N/A
- EPS Growth
- CLPS N/A
- TENX N/A
- EPS
- CLPS N/A
- TENX N/A
- Revenue
- CLPS $164,481,414.00
- TENX N/A
- Revenue This Year
- CLPS N/A
- TENX N/A
- Revenue Next Year
- CLPS N/A
- TENX N/A
- P/E Ratio
- CLPS N/A
- TENX N/A
- Revenue Growth
- CLPS 15.17
- TENX N/A
- 52 Week Low
- CLPS $0.80
- TENX $4.50
- 52 Week High
- CLPS $1.88
- TENX $8.24
- Technical
- Relative Strength Index (RSI)
- CLPS 43.77
- TENX 45.76
- Support Level
- CLPS $0.84
- TENX $6.51
- Resistance Level
- CLPS $0.90
- TENX $7.31
- Average True Range (ATR)
- CLPS 0.05
- TENX 0.46
- MACD
- CLPS -0.01
- TENX -0.07
- Stochastic Oscillator
- CLPS 25.87
- TENX 52.06
About CLPS CLPS Incorporation
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.